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PuriﬁcationMycobacterium leprae, etiologic agent of leprosy, is propagated in athymic nude mouse footpads (FPs). The
current puriﬁcation protocol is tedious and physically demanding. A simpler, semi-automated protocol was
developed using gentleMACS™ Octo Dissociator. The gentleMACS protocol provided a very effective means for
puriﬁcation of highly viableM. leprae from tissue.al Hansen's Disease Programs,
ip Bertman Dr., Baton Rouge,
9856.© 2014 Published by Elsevier B.V.Mycobacterium leprae, the causative agent of leprosy, cannot be
grown axenically. The preferred system for cultivation of highly viable
M. leprae for research purposes is the athymic nude mouse footpad
(FP) model consisting of injecting M. leprae into each of the hind FP
of nude mice and puriﬁcation of bacteria from FP tissues 5–7 months
postinfection (Truman and Krahenbuhl, 2001). The current protocol
for puriﬁcation of highly viable bacteria from this model requires ex-
tensive mincing of the tissue with scissors, the production of a tissue
homogenate using a hand-held glass tissue grinder and differential
centrifugation (Truman and Krahenbuhl, 2001). Although this tech-
nique produces highly puriﬁed, viable M. leprae, it is tedious, physi-
cally demanding and time consuming, especially when M. leprae is
being harvested from large numbers of infected mice within a short
time frame. Therefore, the objective of this study was to develop a
simpler, semi-automated protocol for puriﬁcation of M. leprae from
infected FP tissues using a gentleMACS™ Dissociator.
These studies were performed under a scientiﬁc protocol reviewed
and approved by the National Hansen's Disease Programs Institutional
Animal Care and Use Committee (Assurance #A3032-01), and were
conducted in accordance with all state and federal laws in adherence
with PHS policy and as outlined in the Guide for the Care and Use ofLaboratory Animals, Eighth Edition. Athymic nu/nu mice (Harlan
Sprague–Dawley, Inc., Indianapolis, IN) were euthanized 5–7 months
postinfection withM. leprae Thai-53. The hind legs were removed and
decontaminated with Betadine for 20 min and rinsed in 4 washes of
70% ethanol. The skin was removed and the FP tissue was excised and
weighed. For the puriﬁcation of M. leprae from FP tissues using the
gentleMACS protocol both feet were dissected into small pieces using
a disposable scalpel. Tissue from a single mouse was added to a
gentleMACS™ M tube (Miltenyi BioTec, www.gentleMACS.com) con-
taining 10 ml RPMI-1640 (Life Technologies, Grand Island, NY) and
50 μg/ml ampicillin (Sigma-Aldrich) (RPMI/Amp). Tissues from 6 mice
were simultaneously dissociated in a single run using the Protein 1 set-
ting of a gentleMACS™ Octo Dissociator (Miltenyi BioTec) for 53 s and
cooled on ice for 2 min, and the process was repeated twice. Each
homogenate was transferred to a sterile 15 ml conical centrifuge tube
and tissue debris was removed by centrifugation at 100 ×g, 2 min at
25 °C. Bacteria were pelleted at 10,000 ×g, 30 min at 4 °C, resuspended
in RPMI/Amp+ 10% FBS (Hyclone Laboratories, Logan, UT) and incu-
bated at 37 °C for 1 h to remove potential microbial contaminants.
Bacterial pellets were treated with 0.1 NaOH for 8 min to remove re-
sidual tissue debris and washed 3× in RPMI 1640 + 10% FBS Amp.
For comparison, M. leprae were also puriﬁed from FP tissues using
the standard hand-held homogenization technique (Truman and
Krahenbuhl, 2001). Brieﬂy, FP tissue from a single mouse was minced
to a ﬁne consistency for 3 min using a sterile pair of curved scissors. Tis-
sue was transferred to a sterile 40 ml glass Wheaton Tenbroeck Tissue
Grinder (Cat #08-414-13D, Fisher Scientiﬁc) and gently homogenized
Table 1
Comparison of gentleMACS vs hand-held homogenization protocols for puriﬁcation ofM. leprae from mouse footpad (FP) tissue.
Protocol Bacterial yielda
AFB/mg FP tissue
% viabilityb Radiorespirometryc
CPM/106 M. leprae
Mean SD Mean SD Mean SD
gentleMACS Octo Dissociator 1.5 × 107 0.59 × 107d 82.5% 4.6% 3435 2056
Hand-held homogenization 3.4 × 107 0.86 × 107 84.5% 6.7% 4203 2592
a Bacterial yield = number of acid fast-stained bacterial counts/mg of FP (n = 6 mice/12 FP).
b % viability = LIVE/DEAD BacLight Bacterial Viability Kit (Molecular Probes).
c Radiorespirometry = Buddemeyer radiorespirometry (CPM)/106 M. leprae (7 d readings).
d Signiﬁcance at p = 0.03 using two-tailed paired t-test.
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sion looked milky. Bacteria were clariﬁed, pelleted, incubated at 37 °C
with Amp, and treated with NaOH as described above. Data from 6
mice per protocolwere analyzed using two-tailed paired t test and com-
pared by group using GraphPad software (www.graphpad.com/
quickcalcs/ttest1.cfm) and considered signiﬁcant at p value ≤ 0.05.
The hand-held homogenization protocol produced ~2-fold more
M. leprae than the gentleMACS protocol according to acid-fast stain
counts (p-value = 0.03) (Truman and Gillis, 2000) (Table 1). No signif-
icant differences were observed in the viability ofM. leprae preparation
using the LIVE/DEAD BacLight Bacterial Viability Kit (Molecular Probes)
(Lahiri et al., 2005) and preparations exhibited similar levels of meta-
bolic activity as determined using Buddemeyer radiorespirometry
(Franzblau, 1988). Scanning electron microscopy using an FEI Quanta
200 scanning electron microscope showed that both bacterial prepara-
tions were relatively free of mouse cellular debris (Fig. 1).Fig. 1. Scanning electron micrographs (10,000× magniﬁcation) of puriﬁed M. leprae
preparations from: A) hand-held homogenization protocol and B) gentleMACS protocol.A novel semi-automated procedure for the puriﬁcation ofM. leprae
from infected tissues has been described. The gentleMACS protocol
uses disposable scalpels and tissue dissociation tubes (M-tubes),
eliminating the need for decontamination, cleaning and sterilizing
of re-useable equipment such as scissors, forceps and glass homog-
enizers required for the hand-held homogenization protocol. Therefore,
the preparation and clean-up time for a harvest is greatly minimized.
The gentleMACS protocol FP homogenization step is automated while
the hand-held method is very tedious and physically demanding, re-
quiring 3 min of mincing with curved scissors prior to at least 5 min
of gentle homogenization with a hand-held glass tissue grinder for
each mouse. In addition, FP tissue from 8 mice can be homogenized in
the gentleMACS Octo Dissociator in the same amount of time it
takes to process the tissue from a single mouse with the hand-held
homogenization method. Bacterial yields are ~2-fold lower with
the gentleMACS protocol however viability and metabolic activity
of M. leprae are comparable with both methods. We anticipate that
this procedure will replace the current hand-held tissue homogeni-
zation protocol for puriﬁcation ofM. leprae from infected tissues for
most research purposes. This will be especially beneﬁcial when
studies require large numbers of mice to be harvested in a short pe-
riod of time, such as is common for vaccine or drug studies which
can require 50–60 mice.
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